Nomura Asset Management
NVCR icon

Nomura Asset Management’s NovoCure NVCR Stock Holding History

Nomura Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-22,880
Closed -$950K – 1554
2023
Q2 		$950K Sell
22,880
-2,941
-11% -$183K ﹤0.01% 812
2023
Q1 		$1.55M Buy
25,821
+629
+2% +$50.3K 0.01% 747
2022
Q4 		$1.85M Buy
25,192
+2,754
+12% +$207K 0.01% 715
2022
Q3 		$1.7M Buy
22,438
+2,438
+12% +$190K 0.01% 702
2022
Q2 		$1.39M Buy
20,000
+2,400
+14% +$181K 0.01% 771
2022
Q1 		$1.46M Hold
17,600
– – 0.01% 789
2021
Q4 		$1.32M Hold
17,600
– – 0.01% 823
2021
Q3 		$2.04M Buy
17,600
+1,200
+7% +$181K 0.01% 703
2021
Q2 		$3.64M Buy
16,400
+1,200
+8% +$233K 0.02% 563
2021
Q1 		$2.01M Buy
15,200
+220
+1% +$34.8K 0.01% 713
2020
Q4 		$2.59M Buy
+14,980
New +$2.05M 0.02% 616

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Nomura Asset Management's NVCR Position: Q3 2023 in Review

Nomura Asset Management sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 22,880 shares — an estimated $950K sold.

Nomura Asset Management first reported a position in NVCR in Q4 2020 and held it in 11 quarters. The position peaked at $3.64M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Nomura Asset Management reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Nomura Asset Management sold 22,880 NovoCure shares in Q3 2023, an estimated $950K.
  • Nomura Asset Management first reported a position in NovoCure in Q4 2020 and held it in 11 quarters.
  • Nomura Asset Management's NovoCure position peaked at $3.64M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Nomura Asset Management's 13F filing for Q3 2023, filed 3 Nov 2023.